Isolated Intraocular Relapse of Pediatric B-cell Precursor Acute Lymphoblastic Leukaemia Following Chimeric Antigen Receptor T-lymphocyte Therapy

Chimeric antigen receptor T-lymphocytes (CAR T) targeting the CD19 surface antigen have achieved a breakthrough in the treatment of multiply relapsed and refractory bone marrow (BM) disease in childhood B-cell precursor acute lymphoblastic leukaemia (B-ALL). The ability of CAR T therapy to treat ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Veys, Delphine, Norton, Alice, Ainsworth, John R, Amrolia, Persis, Lucchini, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556410/
https://www.ncbi.nlm.nih.gov/pubmed/33062462
http://dx.doi.org/10.7759/cureus.10937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556410/
https://www.ncbi.nlm.nih.gov/pubmed/33062462
http://dx.doi.org/10.7759/cureus.10937

Ejemplares similares